Preprint · OA
via OpenAlex
Mesenchymal stem cells at the intersection of cell and gene therapy
Timothy J Myers, Froilán Granero‐Moltó, Lara Longobardi, Tieshi Li, Yun Yan, Anna Spagnoli
Expert Opinion on Biological Therapy · 2010 · ▲ 105 citations
Stem-cell exhaustion
Chronic inflammation
Gene therapy
Stem-cell therapy
Partial reprogramming (OSK)
Review
Abstract
IMPORTANCE OF THE FIELD: Mesenchymal stem cells have the ability to differentiate into osteoblasts, chondrocytes and adipocytes. Along with differentiation, MSCs can modulate inflammation, home to damaged tissues and secrete bioactive molecules. These properties can be enhanced through genetic-modification that would combine the best of both cell and gene therapy fields to treat monogenic and multigenic diseases. AREAS COVERED IN THIS REVIEW: Findings demonstrating the immunomodulation, homing and paracrine activities of MSCs followed by a summary of the current research utilizing MSCs as a vector for gene therapy, focusing on skeletal disorders, but also cardiovascular disease, ischemic damage and cancer. WHAT THE READER WILL GAIN: MSCs are a possible therapy for many diseases, especially those related to the musculoskeletal system, as a standalone treatment, or in combination with factors that enhance the abilities of these cells to migrate, survive or promote healing through anti-inflammatory and immunomodulatory effects, differentiation, angiogenesis or delivery of cytolytic or anabolic agents. TAKE HOME MESSAGE: Genetically-modified MSCs are a promising area of research that would be improved by focusing on the biology of MSCs that could lead to identification of the natural and engrafting MSC-niche and a consensus on how to isolate and expand MSCs for therapeutic purposes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1517/14712598.2010.531257
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Myers, T.J., Granero‐Moltó, F., Longobardi, L., Li, T., Yan, Y., & Spagnoli, A. (2010). Mesenchymal stem cells at the intersection of cell and gene therapy. <em>Expert Opinion on Biological Therapy</em>. https://doi.org/10.1517/14712598.2010.531257
Vancouver
Myers TJ, Granero‐Moltó F, Longobardi L, Li T, Yan Y, Spagnoli A. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opinion on Biological Therapy. 2010. doi:10.1517/14712598.2010.531257.
BibTeX
@unpublished{timothy2010Mesenc,
title = {Mesenchymal stem cells at the intersection of cell and gene therapy},
author = {Timothy J Myers and Froilán Granero‐Moltó and Lara Longobardi and Tieshi Li and Yun Yan and Anna Spagnoli},
journal = {Expert Opinion on Biological Therapy},
year = {2010},
doi = {10.1517/14712598.2010.531257},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Signal Transduction and Targeted Therapy 2025
Open access · CC-BY
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
Stem Cells International 2016
Open access · CC-BY
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
World Journal of Stem Cells 2010
Open access · CC-BY
Mesenchymal stem cells: Molecular characteristics and clinical applications
Circulation Research 2011
Open access · OA
Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Current Pharmaceutical Design 2013
Open access · OA
Mesenchymal Stem/Stromal Cells: A New ''Cells as Drugs'' Paradigm. Efficacy and Critical Aspects in Cell Therapy
Cellular and Molecular Life Sciences 2020
Open access · CC-BY